Sjögren's disease & overlap diseases

Novel autoantibodies help diagnose anti-SSA antibody negative Sjögren disease and predict abnormal labial salivary gland pathology

Ann Rheum DisPublished Diagnostic accuracy study

Authors' conclusion

We present novel autoantibodies in SSA- SjD that have good predictive value for SSA- SjD and FS positivity.

Study context

Population
Anti-SSA antibody negative sjögren disease (SjD) cases and controls (independent validation cohort)independent validation cohort
Participants
76 / 75 / 41
Comparison
SSA- SjD vs sicca-controls and autoimmune-feature controls
  • SSA- SjDn = 76
  • Sicca-controlsn = 75reference
  • Autoimmune-feature controlsn = 41reference
Outcome
Novel autoantibodies (IgG peptide binding) to diagnose seronegative SjD
Methodological detailspeptidome array discovery, independent validation cohort, logistic regression with cross-validation
  • Peptidome array discovery
  • Independent validation cohort
  • Logistic regression with cross-validation

Performance

As reported in the abstract

IgG binding to DTD2 peptide
  • SSA- SjD vs Sicca-controls: P = 0.004
  • SSA- SjD vs Combined controls: P = 0.003

Further findings

OutcomeP value
IgG binding, FS-positive vs FS-negativeFS-positive vs FS-negativeP = 0.010
IgG binding, FS-positive vs FS-negativeFS-positive vs FS-negative · DTD2 peptide; bound more in FS-positiveP = 0.012
  • IgG binding, focus score (FS)-positive vs FS-negative: retroelement silencing factor-1 peptide; bound more in FS-positive

Predictive model incorporating clinical variables, discrimination

AUC, SjD vs control
74%
AUC, FS-positive vs FS-negative
72%
  • Good discrimination

Original publication

Novel autoantibodies help diagnose anti-SSA antibody negative Sjögren disease and predict abnormal labial salivary gland pathology. Ann Rheum Dis. Published 27 August 2024. doi:10.1136/ard-2023-224936

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.